105 related articles for article (PubMed ID: 16845219)
1. Anticonvulsant and acute neurotoxic characteristics of nicotinic acid benzylamide: a preclinical study.
Swiader MJ; Łuszczki JJ; Paruszewski R; Czuczwar SJ; Turski WA
Pharmacol Rep; 2006; 58(3):431-4. PubMed ID: 16845219
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the anticonvulsant profile of isonicotinic acid benzylamide in various experimental seizure models in mice.
Luszczki JJ; Swiader MJ; Swiader K; Paruszewski R; Turski WA; Czuczwar SJ
Neurosci Lett; 2007 Jun; 421(1):87-90. PubMed ID: 17548162
[TBL] [Abstract][Full Text] [Related]
3. Protective action of nicotinic acid benzylamide in a variety of chemically-induced seizures in mice.
Świąder MJ; Łuszczki JJ; Paruszewski R; Świąder K; Turski WA
Pharmacol Rep; 2016 Apr; 68(2):297-300. PubMed ID: 26922531
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the anticonvulsant potency of various benzylamide derivatives in the mouse maximal electroshock-induced seizure threshold model.
Świąder MJ; Paruszewski R; Łuszczki JJ
Pharmacol Rep; 2016 Apr; 68(2):259-62. PubMed ID: 26922525
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant and acute adverse effect profiles of picolinic acid 2-fluoro-benzylamide in various experimental seizure models and chimney test in mice.
Luszczki JJ; Swiader MJ; Swiader K; Paruszewski R; Turski WA; Czuczwar SJ
Fundam Clin Pharmacol; 2008 Feb; 22(1):69-74. PubMed ID: 18005356
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: a comparative study.
Luszczki JJ; Wojda E; Andres-Mach M; Cisowski W; Glensk M; Glowniak K; Czuczwar SJ
Epilepsy Res; 2009 Aug; 85(2-3):293-9. PubMed ID: 19406619
[TBL] [Abstract][Full Text] [Related]
7. Stability of two new anticonvulsants in body fluids and tissues.
Goldnik A; Marszałek D; Paruszewski R; Stables JP
Acta Pol Pharm; 2004; 61(4):263-6. PubMed ID: 15575592
[TBL] [Abstract][Full Text] [Related]
8. Influence of WIN 55,212-2 on the anticonvulsant and acute neurotoxic potential of clobazam and lacosamide in the maximal electroshock-induced seizure model and chimney test in mice.
Florek-Luszczki M; Zagaja M; Luszczki JJ
Epilepsy Res; 2014 Dec; 108(10):1728-33. PubMed ID: 25458536
[TBL] [Abstract][Full Text] [Related]
9. Influence of imperatorin on the anticonvulsant activity and acute adverse-effect profile of lamotrigine in maximal electroshock-induced seizures and chimney test in mice.
Luszczki JJ; Wojda E; Raszewski G; Głowniak K; Czuczwar SJ
Pharmacol Rep; 2008; 60(4):566-73. PubMed ID: 18799827
[TBL] [Abstract][Full Text] [Related]
10. 7-Nitroindazole potentiates the anticonvulsant action of some second-generation antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar M; Gawlik P; Sawiniec-Pozniak G; Czuczwar K; Czuczwar SJ
J Neural Transm (Vienna); 2006 Sep; 113(9):1157-68. PubMed ID: 16465466
[TBL] [Abstract][Full Text] [Related]
11. Ralitoline: a reevaluation of anticonvulsant profile and determination of "active" plasma concentrations in comparison with prototype antiepileptic drugs in mice.
Löscher W; von Hodenberg A; Nolting B; Fassbender CP; Taylor C
Epilepsia; 1991; 32(4):560-8. PubMed ID: 1868813
[TBL] [Abstract][Full Text] [Related]
12. Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis.
Luszczki JJ; Czuczwar SJ
Epilepsia; 2004 Aug; 45(8):895-907. PubMed ID: 15270754
[TBL] [Abstract][Full Text] [Related]
13. 7-Nitroindazole, but not NG-nitro-L-arginine, enhances the anticonvulsant activity of pregabalin in the mouse maximal electroshock-induced seizure model.
Łuszczki JJ; Jaskólska A; Dworzański W; Zółkowska D
Pharmacol Rep; 2011; 63(1):169-75. PubMed ID: 21441625
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and pharmacological evaluation of alpha-substituted N-benzylamides of gamma-hydroxybutyric acid with potential GABA-ergic activity. Part 6. Search for new anticonvulsant compounds.
Malawska B; Kulig K; Gajda J; Szczeblewski D; Musiał A; Wieckowski K; Maciag D; Stables JP
Acta Pol Pharm; 2007; 64(2):127-37. PubMed ID: 17665862
[TBL] [Abstract][Full Text] [Related]
15. Influence of N-hydroxymethyl-p-isopropoxyphenylsuccinimide on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Kominek M; Florek-Luszczki M; Tchaytchian DA; Kocharov SL; Zolkowska D
Epilepsy Res; 2012 Jun; 100(1-2):27-36. PubMed ID: 22281062
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the anticonvulsant activity of doxepin in various experimental seizure models in mice.
Sun XY; Zhang L; Wei CX; Piao HR; Quan ZS
Pharmacol Rep; 2009; 61(2):245-51. PubMed ID: 19443935
[TBL] [Abstract][Full Text] [Related]
17. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices.
Löscher W; Nolting B
Epilepsy Res; 1991; 9(1):1-10. PubMed ID: 1884714
[TBL] [Abstract][Full Text] [Related]
18. New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones.
Kamiński K; Zagaja M; Rapacz A; Łuszczki JJ; Andres-Mach M; Abram M; Obniska J
Bioorg Med Chem; 2016 Feb; 24(4):606-18. PubMed ID: 26746343
[TBL] [Abstract][Full Text] [Related]
19. Characterization and preliminary anticonvulsant assessment of some 1,3,4-thiadiazole derivatives.
Luszczki JJ; Karpińska M; Matysiak J; Niewiadomy A
Pharmacol Rep; 2015 Jun; 67(3):588-92. PubMed ID: 25933973
[TBL] [Abstract][Full Text] [Related]
20. New derivatives of benzylamide with anticonvulsant activity.
Strupińska M; Rostafińska-Suchar G; Stables JP; Paruszewski R
Acta Pol Pharm; 2009; 66(2):155-9. PubMed ID: 19719049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
